Clinical Trials Directory

Trials / Completed

CompletedNCT02158208

Study of the T CD8 Immune Response in Horton's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The research hypothesis is that T lymphocytes CD8 play a role in the physiopathology of Horton's disease. At the inclusion visit, patients will have, as is the case in the usual strategy: * A complete clinical examination carried out by the doctor in charge of the patient * ESR, and CRP and fibrinogen assay * A full blood count for leukocytes and lymphocytes * A biopsy of the temporal artery (TAB) to screen for signs of vascularitis, suggesting Horton's disease. The clinician in charge of the patient will decide if a second biopsy is necessary. The biopsy will be sent to and analysed at Anatomy and Pathological cytology service. Immunohistochemical analyses will be done if the TAB is positive. In addition to the standard clinical examination and complementary examinations relative to the patients' pathology, the following will be done: * Lymphocyte immunophenotyping for the quantity of T CD4 (cluster of differentiation 4) and CD8 lymphocytes, B lymphocytes and natural killer lymphocytes. This will make it possible to calculate the absolute value for different T lymphocyte populations. * A blood sample drawn into a dry 5 mL tube (large yellow) to isolate the serum, which will be stored at -80°C for future assays for cytokines and other biomarkers of interest for Horton's disease. * 16 blood samples drawn into 6 mL heparinized tubes (large green). These will be used immediately for cytometric and functional analyses.

Conditions

Interventions

TypeNameDescription
OTHERBlood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment
OTHER16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment
OTHERBlood sample drawn into a 5 mL dry tube
OTHER16 blood samples drawn into 6 mL heparinized tubes

Timeline

Start date
2013-07-25
Primary completion
2016-01-25
Completion
2016-01-25
First posted
2014-06-06
Last updated
2026-03-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02158208. Inclusion in this directory is not an endorsement.